Acta Diabetologica

, Volume 55, Issue 9, pp 985–986 | Cite as

A new experience for incorrect insulin administration

  • Cem Onur KiracEmail author
  • Suleyman Hilmi Ipekci
  • Levent Kebapcilar
Letter to the Editor


Diabetes mellitus treatment Patient education Treatment incompatibility Incorrect insulin usage Type 2 diabetes mellitus 


Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

All procedures were followed in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration.

Informed consent

Written informed consent was obtained from patient.


  1. 1.
    Pozzuoli GM, Laudato M, Barone M et al (2018) Errors in insulin treatment management and risk of lipohypertrophy. Acta Diabetol 55:67–73CrossRefPubMedGoogle Scholar
  2. 2.
    Mohan V, Shah SN, Joshi SR et al (2014) Current status of management, control, complications and psychosocial aspects of patients with diabetes in India: Results from the DiabCare India 2011 Study. Indian J Endocrinol Metab 18:370–378CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Blanco M, Hernandez MT, Strauss KW et al (2013) Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab 39:445–453CrossRefPubMedGoogle Scholar
  4. 4.
    Kuniss N, Müller UA, Kloos C et al (2018) Substantial improvement in HbA1c following a treatment and teaching programme for people with type 2 diabetes on conventional insulin therapy in an in- and outpatient setting. Acta Diabetol 55:131–137CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Endocrinology and Metabolism, Internal Medicine Department, Faculty of MedicineSelcuk UniversityKonyaTurkey

Personalised recommendations